According to the overall guidelines of the "Eleventh Five-Year Plan" for the development of high-tech industries, the National Development and Reform Commission recently released the "Eleventh Five-Year Plan" (hereinafter referred to as the "Plan") for the industrialization of high-tech sectors. The plan emphasizes the strategic deployment of key areas such as biotechnology and information technology, with a focus on large-scale industrialization of high-tech products. It aims to drive innovation, enhance self-reliance in technological development, promote economic restructuring, and boost the industry’s core competitiveness.
The "Plan" highlights the need to accelerate the development of genetic engineering drugs, new chemical synthesis medicines, innovative vaccines, and diagnostic reagents. It also promotes the industrialization of modern Chinese medicine and biomedical engineering products, with an emphasis on cultivating bio-pharmaceuticals that have independent intellectual property rights. During the "11th Five-Year Plan" period, the government will prioritize 16 special projects in high-tech industrialization, including biomedicine, modern Chinese medicine, biomedical engineering, and biomass engineering.
In the field of bio-pharmaceuticals, the plan prioritizes the development of bio-drugs with strong market potential and independent IP. It encourages breakthroughs in genetic engineering and antibody therapies, while promoting the development of small-molecule drugs, advanced drug delivery systems, and new formulations. It also focuses on creating new preventive and therapeutic vaccines, especially for emerging pathogens, and improving treatment for major diseases like cancer, cardiovascular conditions, and infectious diseases such as AIDS and hepatitis.
For modern Chinese medicine, the plan emphasizes the development of new herbal medicines, standardized decoctions, and high-quality plant-based products with clear pharmacological effects and minimal side effects. It also supports the modernization of traditional Chinese medicine production techniques and the treatment of chronic and complex diseases, aiming to expand the global reach of Chinese medicine.
In biomedical engineering, the plan encourages the development of advanced implants, artificial organs, and tissue engineering products. It also promotes the industrialization of medical imaging equipment, such as MRI, CT, and digital X-ray machines, ensuring they are cost-effective, user-friendly, and capable of meeting national healthcare needs while entering international markets.
To support these efforts, the government is enhancing its investment and financing mechanisms. It will increase financial support through interest subsidies and guided funds, encouraging venture capital investments in early-stage high-tech projects. Additionally, it will assist local governments and institutions in setting up venture capital funds to attract broader social and financial participation, forming a diversified and multi-level funding system for high-tech industrialization.
Reports indicate that less than 1% of biotech compounds are developed into actual drugs, requiring significant investment. To bridge this gap, the state is focusing on improving the investment environment and supporting key innovations through various financial instruments.
Currently, there are over 60 biopharmaceutical industrial parks under construction across China, playing a vital role in attracting overseas talent and accelerating the commercialization of biotech research. However, many parks suffer from fragmentation and lack of specialization, limiting their ability to create industrial agglomeration effects.
To further advance the bio-industry, the National Development and Reform Commission outlined four key tasks in 2004: formulating a comprehensive bio-industry plan, improving policies to support bio-industry growth, promoting the industrialization of biotechnology, and strengthening innovation in the sector. During the "10th Five-Year Plan," annual special projects were implemented, with nearly 400 billion yuan invested in biotech industrialization.
Low Alloy Steel Welding Electrodes
LOW ALLOY STEEL Welding Electrode:
Low alloy steel electrode is a kind of electrode that requires good plasticity, high impact toughness, good low temperature performance and strong crack resistance.
Low alloy steel electrodes are divided into the following three categories:
1. Structural steel electrodes above 50 kg (except deposited metal Mn-Si series)
2. Molybdenum and lattice molybdenum pearlitic heat-resistant steel electrode
3. Low temperature steel welding rod
If you have any questions, please contact with us directly. Welcome you can visit our factory for inquiry, please send mail directly to us.
Low Alloy Steel Welding Electrodes,Low Carbon Steel Welding Rod,Low Alloy Electrode,Low Alloy Steel Electrode
JIANGSU FUERMU WELDING CORPORATION , https://www.fuermuwelding.com